Further studies have suggested that targeting TLR4 exerted a neuroprotective role in resisting ICH-induced brain injury by impeding the Prx1/TLR4/NFκB signaling axis at 3 days after ICH, providing a promising anti-neuroinflammatory approach for hemorrhagic stroke (Liu et al., 2016). This evidence concerns the gene TLR4 and hemorrhagic stroke.